Leading Biotechnology Alliances

Description

"Leading Biotechnology Alliances presents a tightly focused discussion regarding issues and questions that are unique and critical to the effectiveness of alliances, including: power differences and other asymmetries between partner firms and some implications for alliance dynamics; sector history and evolution as a basis for understanding the cultural divide that characterizes many biotechnology-pharmaceutical relationships; why leaders on the biotechnology side must assume the greater leadership responsibility in these alliances; different - and predictable - challenges over the alliance life cycle, from start to completion/termination; and leadership roles needed for productive and effective collaboration across groups, locations, and companies." "From societal and economic perspectives, it is important to lead biotechnology alliances right, right from the start. The intent of Leading Biotechnology Alliances is to help scientists and executives from large and small companies do just that - collaborate productively and effectively. This book includes a case study, numerous interview excerpts, general theory and background, a delineation of alliance responsibilities, and a set of alliance effectiveness questions. Together, these ingredients provide the reader with a clear understanding of the complicated dynamics of alliances and leadership issues and roles within the alliance life cycle."--Jacket.

First Sentence

Research alliances between small biotechnology companies and large pharmaceutical firs play a crucial role in helping to "close the innovation gap" in the biopharmaceutical industry; and, they are expected to be a major source of new therapeutics in years to come.

Subjects